FINANCIAL SUMMARY - FOURTH QUARTER 2020
Qlife hires Jakob Broberg Lind as Sales Director Clinical
Jakob has extensive experience from international sales and business development within MedTech and healthcare and brings an excellent record of results and achievements in complex and competitive business environments. He comes from the role of Nordic Sales Manager & Strategic Account Manager at Boston Scientific.
“Qlife has a very strong team with an excellent reputation for developing diagnostic devices and biochemistry, and we are on a mission to make blood testing easier, smarter and better for everyone. To establish a position in the clinical market for the paradigm shifting Egoo system, we need an experienced sales professional to shape the sales strategy towards the B2B audiences in the healthcare sector – and we are extremely happy to have recruited Jakob,” says Thomas Warthoe, CEO of Qlife.
“To bring the game-changing Egoo system to the market is a unique opportunity, and I am very excited to join Qlife’s journey. With Qlife's product portfolio, pipeline and recognized expertise, I know that we are equipped to lead the revolutionary and inevitable change in blood testing and analysis. Qlife’s mobile and decentral solutions will save resources for both the individual and the healthcare system,” Jakob Broberg Lind says.
Initially focusing on the Nordic countries, Sales Director Clinical Jakob Broberg Lind will be globally responsible for designing, planning and executing initiatives that drive awareness, lead generation and sales, as well as for developing service products and payment models. His responsibility covers the full product range, mainly towards the clinical segment, i.e. hospitals, healthcare facilities, clinics, and the pharmaceutical industry. He will be running direct sales processes, as well as establishing sales partnerships with e.g. distributors and licensees. Jakob will also be responsible for the coming year's expansion of the commercial organization, covering sales, logistics and customer service. Jakob has a given place in Qlife’s executive management team in which he will contribute to the overall business development in addition to developing the company's sales.
“It is of great importance for Qlife to get a significant order from a highly professional customer directly after the CE-marking.
The Danish Patent Office has granted Qlife patent number DK180348 B1 for its biomarker detection unit.
The current CE-mark applies to the professional use of the test platform Egoo.Health for sale on the European market.
Qlife expects to CE mark its COVID-19 test for professional use in the Egoo.Health system within short.
Since May 2020, Qlife has been handling all testing for COVID-19 for professional football in Denmark.
On November 13, Qlife was informed that the Danish Medicines Agency (Lægemiddelstyrelsen) had rejected the application for temporay approval in Denmark “in the interest of health protection” for th
”We will do our utmost to protect the participating players against the coronavirus”, says Frank Smith, Covid-19 Officer, European Handball Federation Euro 2020 “It requires testing with high preci
Resolution on (A) employee option program; and (B) directed issue of warrants and approval of transfer of warrants